Sunday 11 October 2026 Export all INNV data to Excel Powerpack

InnovAge Holding Corp.

INNV Healthcare Medical Care Facilities

InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025. In the quarter to June 2026, revenue grew 18.3%, EPS grew 700.0%, free cash flow grew 85.4% and total debt fell 16.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.10 0.01 −0.11%
Market cap
$1.2B
P/E
0.0×
Fwd P/E
17.2×
Dividend yield
—
F-score
6/9
Altman Z
4.58
Beneish M
−3.10
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19
Revenue
989.71 853.70 763.86 688.09 698.64 637.80 567.19 465.63
Revenue Growth
15.93% 11.76% 11.01% (1.51%) 9.54% 12.45% 21.81% (17.91%)
Cost of Revenue
761.94 700.06 631.79 586.80 563.27 463.72 425.89 355.00
Gross Profit
227.76 153.64 132.06 101.29 135.37 174.08 141.30 110.63
SG&A Expenses
200.85 150.28 136.29 135.26 125.85 154.57 77.48 64.71
Operating Income
2.62 (29.76) (23.18) (49.40) (4.41) (12.34) 50.93 39.68
Non-operating Income/Expense
(2.35) (4.27) 1.36 (1.40) (2.83) (22.63) (15.30) (14.29)
Non-operating Interest Expenses
4.26 4.61 4.02 1.52 2.53 16.79 14.62 9.59
EBT
0.27 (34.03) (21.82) (50.79) (7.24) (34.97) 35.63 25.39
Income Tax Provision
0.95 1.32 1.40 (7.24) 0.72 9.77 9.87 6.32
Income after Tax
(0.68) (35.34) (23.22) (43.55) (7.96) (44.74) 25.77 19.07
Dividends (Preferred)
— 0.00 0.00 0.00 — — — —
Non-Controlling Interest
1.85 (5.03) (1.88) (2.88) (1.44) (0.75) (0.51) (0.51)
Net Income Common
(2.54) (30.31) (21.34) (40.67) (6.52) (43.99) 26.28 19.58
EPS (Basic)
(0.02) (0.22) (0.16) (0.30) (0.05) (0.36) 0.19 0.14
EPS (Diluted)
(0.02) (0.22) (0.16) (0.30) (0.05) (0.36) 0.19 0.14
Shares (Basic, Weighted)
135.70 135.39 135.90 135.59 135.52 123.62 132.62 132.32
Shares (Diluted, Weighted)
135.70 135.39 135.90 135.59 135.52 123.62 135.23 134.03
Gross Margin
23.01% 18.00% 17.29% 14.72% 19.38% 27.29% 24.91% 23.76%
EBIT Margin
0.26% (3.49%) (3.03%) (7.18%) (0.63%) (1.93%) 8.98% 8.52%
EBT margin
0.03% (3.99%) (2.86%) (7.38%) (1.04%) (5.48%) 6.28% 5.45%
Net Profit Margin
(0.26%) (3.55%) (2.79%) (5.91%) (0.93%) (6.90%) 4.63% 4.20%
Free Cash Flow Margin
5.47% 3.12% (5.87%) (0.45%) (1.57%) (4.25%) 5.67% 2.45%
EBITDA
24.53 (9.82) (3.80) (33.55) 9.95 1.01 62.77 49.60
EBIT
2.62 (29.76) (23.18) (49.40) (4.41) (12.34) 50.93 39.68
Income from Continuous Operations
(0.68) (35.34) (23.22) (43.55) (7.96) (44.74) 25.77 19.07
Consolidated Net Income/Loss
(0.68) (35.34) (23.22) (43.55) (7.96) (44.74) 25.77 19.07
EPS (Basic, from Continuous Ops)
0.00 (0.26) (0.17) (0.32) (0.06) (0.36) 0.19 0.14
EPS (Basic, Consolidated)
0.00 (0.26) (0.17) (0.32) (0.06) (0.36) 0.19 0.14
EPS (Diluted, from Cont. Ops)
0.00 (0.26) (0.17) (0.32) (0.06) (0.36) 0.19 0.14
Shares (Diluted, Average)
135.70 135.39 135.90 135.59 135.52 123.62 — —
EPS (Diluted, Consolidated)
0.00 (0.26) (0.17) (0.32) (0.06) (0.36) 0.19 0.14
EBITDA Margin
2.48% (1.15%) (0.50%) (4.88%) 1.42% 0.16% 11.07% 10.65%
Operating Cash Flow Margin
6.54% 3.85% (4.83%) 2.94% 3.91% (1.18%) 7.73% 5.56%

Fold the line items

In millions of $ except per-share values · columns are period end dates